日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression

对接受强化治疗策略的高危冒烟型多发性骨髓瘤患者进行基因组分析,揭示了潜在的耐药和进展标志物。

Medina-Herrera, A; Vazquez, I; Cuenca, I; Rosa-Rosa, J M; Ariceta, B; Jimenez, C; Fernandez-Mercado, M; Larrayoz, M J; Gutierrez, N C; Fernandez-Guijarro, M; Gonzalez-Calle, V; Rodriguez-Otero, P; Oriol, A; Rosiñol, L; Alegre, A; Escalante, F; De La Rubia, J; Teruel, A I; De Arriba, F; Hernandez, M T; Lopez-Jimenez, J; Ocio, E M; Puig, N; Paiva, B; Lahuerta, J J; Bladé, J; San Miguel, J F; Mateos, M V; Martinez-Lopez, J; Calasanz, M J; Garcia-Sanz, R

Measurable residual disease (MRD) dynamics in multiple myeloma and the influence of clonal diversity analyzed by artificial intelligence

利用人工智能分析多发性骨髓瘤中可测量残留病灶(MRD)的动态变化以及克隆多样性的影响

Martinez-Lopez, J; Lopez-Muñoz, N; Chari, A; Dorado, S; Barrio, S; Arora, S; Kumar, A; Chung, A; Martin, T; Wolf, J

Large-scale real-life analysis of survival and usage of therapies in multiple myeloma

对多发性骨髓瘤患者的生存率和治疗使用情况进行大规模真实世界分析

Lopez-Muñoz, N; Hernández-Ibarburu, G; Alonso, R; Sanchez-Pina, J M; Ayala, R; Calbacho, M; Cuellar, C; Cedena, M T; Jiménez-Ubieto, A; Iñiguez, R; Pedrera, M; Cruz, J; Meloni, L; Pérez-Rey, D; Serrano, P; de la Cruz, J; Martinez-Lopez, J

Correction: Large-scale real-life analysis of survival and usage of therapies in multiple myeloma

更正:大规模真实世界多发性骨髓瘤生存率和治疗使用情况分析

Lopez-Muñoz, N; Hernández-Ibarburu, G; Alonso, R; Sanchez-Pina, J M; Ayala, R; Calbacho, M; Cuellar, C; Cedena, M T; Jiménez-Ubieto, A; Iñiguez, R; Pedrera, M; Cruz, J; Meloni, L; Pérez-Rey, D; Serrano, P; de la Cruz, J; Martinez-Lopez, J

Impaired FADD/BID signaling mediates cross-resistance to immunotherapy in Multiple Myeloma.

FADD/BID信号传导受损介导多发性骨髓瘤对免疫疗法的交叉耐药性

Munawar Umair, Zhou Xiang, Prommersberger Sabrina, Nerreter Silvia, Vogt Cornelia, Steinhardt Maximilian J, Truger Marietta, Mersi Julia, Teufel Eva, Han Seungbin, Haertle Larissa, Banholzer Nicole, Eiring Patrick, Danhof Sophia, Navarro-Aguadero Miguel Angel, Fernandez-Martin Adrian, Ortiz-Ruiz Alejandra, Barrio Santiago, Gallardo Miguel, Valeri Antonio, Castellano Eva, Raab Peter, Rudert Maximilian, Haferlach Claudia, Sauer Markus, Hudecek Michael, Martinez-Lopez J, Waldschmidt Johannes, Einsele Hermann, Rasche Leo, Kortüm K Martin

P890: THE OUTCOME OF SECOND PRIMARY MALIGNANCIES DEVELOPING IN MM PATIENTS

P890:多发性骨髓瘤患者继发原发性恶性肿瘤的结局

Gramatges, Maria M; Winter, Stuart S; Avivi, I; H vesole, D; Dávila Valls, J; Usnarska-Zubkiewicz, L; Milunovic, V; Bogumiła Osękowska, B B; Kopińska, A; Gentile, M; MARTÍNEZ, B P; Robak, P; crusoe, E; LUIS GERARDO, R; Gajewska, M; Gergely, V; Delforge, M; Cohen, Y; Alessandro, G; peña, C; Shustik, C; Mikala, G; Žalac, K; Denis, A H; Peter, B; Weisel, K; martinez lopez, J; Waszczuk-Gajda, A; Krzystanski, M; Jurczyszyn, A

Impact of COVID-19 in patients with multiple myeloma based on a global data network

基于全球数据网络的 COVID-19 对多发性骨髓瘤患者的影响

Martinez-Lopez, J; Hernandez-Ibarburu, G; Alonso, R; Sanchez-Pina, J M; Zamanillo, I; Lopez-Muñoz, N; Iñiguez, Rodrigo; Cuellar, C; Calbacho, M; Paciello, M L; Ayala, R; García-Barrio, N; Perez-Rey, D; Meloni, L; Cruz, J; Pedrera-Jiménez, M; Serrano-Balazote, P; de la Cruz, J

IL-1R blockade is not effective in patients with hematological malignancies and severe SARS-CoV-2 infection

IL-1R阻断疗法对患有血液系统恶性肿瘤和严重SARS-CoV-2感染的患者无效。

Villegas, Carolina; Poza, María; Talayero, Paloma; Teller, José Manuel Caro; Zafra, Denis; Garcia, Cristina; Vera, Elena; Hidalgo, Marta; Lopez, Nieves; Cuellar, Clara; Zamanillo, Irene; Íñiguez, Rodrigo; Paz-Artal, Estela; Aguado, José M; Martinez-Lopez, J

Differentiation stage of myeloma plasma cells: biological and clinical significance

骨髓瘤浆细胞分化阶段:生物学和临床意义

Paiva, B; Puig, N; Cedena, M T; de Jong, B G; Ruiz, Y; Rapado, I; Martinez-Lopez, J; Cordon, L; Alignani, D; Delgado, J A; van Zelm, M C; Van Dongen, J J M; Pascual, M; Agirre, X; Prosper, F; Martín-Subero, J I; Vidriales, M-B; Gutierrez, N C; Hernandez, M T; Oriol, A; Echeveste, M A; Gonzalez, Y; Johnson, S K; Epstein, J; Barlogie, B; Morgan, G J; Orfao, A; Blade, J; Mateos, M V; Lahuerta, J J; San-Miguel, J F

Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale

建立和评估国际尺度上用于 BCR-ABL1 定量检测的二级参考面板

Cross, N C P; White, H E; Ernst, T; Welden, L; Dietz, C; Saglio, G; Mahon, F-X; Wong, C C; Zheng, D; Wong, S; Wang, S-S; Akiki, S; Albano, F; Andrikovics, H; Anwar, J; Balatzenko, G; Bendit, I; Beveridge, J; Boeckx, N; Cerveira, N; Cheng, S-M; Colomer, D; Czurda, S; Daraio, F; Dulucq, S; Eggen, L; El Housni, H; Gerrard, G; Gniot, M; Izzo, B; Jacquin, D; Janssen, J J W M; Jeromin, S; Jurcek, T; Kim, D-W; Machova-Polakova, K; Martinez-Lopez, J; McBean, M; Mesanovic, S; Mitterbauer-Hohendanner, G; Mobtaker, H; Mozziconacci, M-J; Pajič, T; Pallisgaard, N; Panagiotidis, P; Press, R D; Qin, Y-Z; Radich, J; Sacha, T; Touloumenidou, T; Waits, P; Wilkinson, E; Zadro, R; Müller, M C; Hochhaus, A; Branford, S